71 related articles for article (PubMed ID: 2661066)
1. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
Lee GS; Woo KT; Lim CH
Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
[No Abstract] [Full Text] [Related]
2. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
3. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Brodsky SV; Rovin BH; Hebert LA
Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
[No Abstract] [Full Text] [Related]
4. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
Woo KT; Lee GS; Pall AA
Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
[No Abstract] [Full Text] [Related]
6. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
Woo KT; Lee GS
Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
[No Abstract] [Full Text] [Related]
7. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
8. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
9. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
Woo KT; Chiang GS; Lim CH
Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
[No Abstract] [Full Text] [Related]
10. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
Woo KT; Chiang GS; Lau YK; Lim CH
Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
[No Abstract] [Full Text] [Related]
11. Clinical effect of dipyridamole in patients with IgA nephropathy.
Yagame M; Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Nov; 11(5):329-33. PubMed ID: 2960035
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Yoshikawa N; Ito H
Nephrol Dial Transplant; 1999 May; 14(5):1097-9. PubMed ID: 10344344
[No Abstract] [Full Text] [Related]
13. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Chan MK; Kwan SY; Chan KW; Yeung CK
Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
[TBL] [Abstract][Full Text] [Related]
15. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
Woo KT; Chiang GS; Yap HK; Lim CH
Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
[TBL] [Abstract][Full Text] [Related]
16. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
Ciavarella N; Antoncecchi S; D'Elia N
Cardiologia; 1985 Apr; 30(4):301-7. PubMed ID: 3914360
[No Abstract] [Full Text] [Related]
17. [Rheological and blood coagulation control during treatment of diffuse kidney diseases].
Zhavoronkov EK; Potapov VV; Potapova IV
Klin Med (Mosk); 1981 Jan; 59(1):57-63. PubMed ID: 7017262
[No Abstract] [Full Text] [Related]
18. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
[TBL] [Abstract][Full Text] [Related]
19. The treatment of glomerulonephritis.
Kincaid-Smith P
Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575
[No Abstract] [Full Text] [Related]
20. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
Zimmerman SW; Moorthy AV; Dreher WH; Friedman A; Varanasi U
Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
